Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010758
Filing Date
2020-05-14
Accepted
2020-05-14 16:11:26
Documents
42
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20200331_10q.htm 10-Q 464733
2 EXHIBIT 10.9 ex_186626.htm EX-10.9 226597
3 EXHIBIT 31.1 ex_173126.htm EX-31.1 17914
4 EXHIBIT 31.2 ex_173127.htm EX-31.2 14568
5 EXHIBIT 32.1 ex_173128.htm EX-32.1 10163
  Complete submission text file 0001437749-20-010758.txt   3164629

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpx-20200331.xml EX-101.INS 403278
7 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20200331.xsd EX-101.SCH 36744
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20200331_cal.xml EX-101.CAL 20126
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20200331_def.xml EX-101.DEF 275499
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20200331_lab.xml EX-101.LAB 247830
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20200331_pre.xml EX-101.PRE 287283
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 20877859
SIC: 2834 Pharmaceutical Preparations